STAT3 deacetylation restricts its binding ability to the Rorc promoter and diminishes Th17 cytokine secretion which consequently reduces vascular endothelial growth factor (VEGF) production and potentially tumor suppression [33]. This evidence concerns the gene VEGFA and neoplasm.